Delivery Order SPE2DR25D2101-SPE2DR26F47ZU
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 23, 2026, for Repatha 140 mg/ml SureClick auto-injectors, valued at $5,758.55. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 26, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,317.04 by the Defense Logistics Agency (DLA) on January 23, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector pharmaceutical product. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by January 26, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 28, 2026, by the Defense Logistics Agency for $11,137.26 to supply Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under full and open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 29,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $33,760.01 by the Defense Logistics Agency on January 27, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The delivery order, which carries an ultimate completion date of January 28, 2026, represents a non-competitive award issued without set-aside designation. Performance will be executed from the awardee's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $44,909.34 by the Defense Logistics Agency on January 28, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the prime contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $6,497.25 delivery order by the Defense Logistics Agency on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen's...
- Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was awarded a delivery order valued at $12,175.92 on January 12, 2026, by the Defense Logistics Agency for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-competitive, firm fixed-price delivery order is expected to be completed by January 13, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,091.56 by the Defense Logistics Agency (DLA) on January 27, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by January 28, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. Repatha is a prescription...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $2,124.05 on January 27, 2026, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 28, 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 23, 2026, for Repatha 140 mg/ml SureClick auto-injector medication. The competitively awarded, firm fixed-price delivery order has a ceiling value of $13,018.84 and an ultimate completion date of January 26, 2026. This award carries no set-aside designation, indicating the contract was competed on a full and open...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47ZUDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $3,671.17 from the Defense Logistics Agency for Repatha 140 mg/ml SureClick auto-injector medication. The award was made on February 3, 2026, with an ultimate completion date of February 4, 2026, and was not designated as a set-aside contract. The place of performance is listed as Conshohocken, Pennsylvania, where Amerisourcebergen's corporate office is headquartered. This delivery order was issued under a firm fixed-price contract structure, reflecting the government's procurement approach for pharmaceutical supplies. This delivery order is executed under Cencora, Inc.'s significant Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This master contract vehicle enables the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Medical Supply Chain relies on such contracts to ensure consistent access to critical pharmaceutical commodities for military treatment facilities and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 2/2/26 |